Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of venlafaxine on quality of life and acute oxaliplatin-induced pain
IRCT20160920029889N6Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of venlafaxine in gastrointestinal cancer, sponsored by Urmia University of Medical Sciences. Primary endpoints: Quality of life and Acute oxaliplatin-induced pain. Started Dec 2024; status: completed.
02
Drugs
venlafaxine
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on IRCT20160920029889N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160920029889N6.